What is the Estimated CAGR of the Anatomic Pathology Market in Coming Years?

According to the United Nations Department of Economic and Social Affairs (UNDESA), the global population of people aged 65 years or above will increase from 727 million in 2020 to more than 1.5 billion by 2050. As age weakens the immune system, the elderly population is highly prone to chronic diseases such as cancer, cardiovascular diseases (CVDs), dementia, diabetes, organ failure, and chronic obstructive pulmonary disease (COPD), which can be diagnosed by using anatomic pathology. Thus, the surging population of the elderly will amplify the need for anatomic pathology tests in the foreseeable future.


Additionally, the rising burden of chronic ailments, such as kidney diseases, cancer, autoimmune diseases, liver cirrhosis, hypertension, and heart diseases, especially in high and low- and middle-income countries (LMICs) will propel the anatomic pathology market at 5.8% CAGR during 2019–2024. According to P&S Intelligence, the market revenue will grow from $17.4 billion in 2018 to $24.3 billion by 2024. As per the World Health Organization (WHO), ischaemic heart disease, stroke, and COPD caused around 16%, 11%, and 6% of the total deaths all over the world, respectively, in 2019.

In recent years, diagnostic laboratories have emerged as the largest users of anatomic pathology consumables and instruments due to the lower cost of the tests conducted in these facilities in comparison to the ones conducted in hospitals and clinics. In addition to diagnostic laboratories and hospitals and clinics, such products are also adopted by ambulatory surgical centers (ASCs) and academic and research organizations for diseases diagnosis and drug discovery purposes. All the end users use reagents, antibodies, probes, kits, slide stainers, cyrostats, tissue processors, and centrifuges for multiple applications. 

Consumables and instruments offered by Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffman–La Roche Ltd., Danaher Corporation, and Bio-Rad Laboratories Inc. are used in the fields of cardiology, nephrology, hepatology, and oncology for conducting surgical pathology, histopathology, and cytopathology tests. In the coming years, the popularity of histopathology tests will soar due to the surging number of tissue-related illnesses, such as infectious diseases and cancer, which can be diagnosed through this test. According to the WHO, cancer accounted for around 10 million deaths in 2020.

Browse full report with Table of Content - Anatomic Pathology Market Insights


Comments

Popular posts from this blog

Huge Growth Expected in Dermacosmetics Market in Future

Increasing Occurrence of Spinal Cord Injuries Powering Sales of Exoskeletons

Why is Population Health Management Market Expected to Boom in North America in Future?